Association of phenylbutazone usage with horses bought for slaughter: A public health risk

被引:17
作者
Dodman, Nicholas [3 ]
Blondeau, Nicolas [4 ]
Marini, Ann M. [1 ,2 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA
[2] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA
[3] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA USA
[4] Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, F-06560 Valbonne, France
关键词
Phenylbutazone; Thoroughbred; Food safety; Residue; Racehorse; Aplastic anemia; Agranulocytosis; APLASTIC-ANEMIA; PHARMACOKINETICS; PONIES;
D O I
10.1016/j.fct.2010.02.021
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Sixty-seven million pounds of horsemeat derived from American horses were sent abroad for human consumption last year. Horses are not raised as food animals in the United States and, mechanisms to ensure the removal of horses treated with banned substances from the food chain are inadequate at best. Phenylbutazone (PBZ) is the most commonly used non-steroidal anti-inflammatory drug (NSAID) in equine practice. Thoroughbred (TB) race horses like other horse breeds are slaughtered for human consumption. Phenylbutazone is banned for use in any animal intended for human consumption because it causes serious and lethal idiosyncratic adverse effects in humans. The number of horses that have received phenylbutazone prior to being sent to slaughter for human consumption is unknown but its presence in some is highly likely. We identified eighteen TB race horses that were given PBZ on race day and sent for intended slaughter by matching their registered name to their race track drug record over a five year period. Sixteen rescued TB race horses were given PBZ on race day. Thus, PBZ residues may be present in some horsemeat derived from American horses. The permissive allowance of such horsemeat used for human consumption poses a serious public health risk. Published by Elsevier Ltd.
引用
收藏
页码:1270 / 1274
页数:5
相关论文
共 22 条
[1]  
[Anonymous], 1986, JAMA, V256, P1749
[2]   PHENYLBUTAZONE LIVER-INJURY - A CLINICAL-PATHOLOGIC SURVEY OF 23 CASES AND REVIEW OF THE LITERATURE [J].
BENJAMIN, SB ;
ISHAK, KG ;
ZIMMERMAN, HJ ;
GRUSHKA, A .
HEPATOLOGY, 1981, 1 (03) :255-263
[3]   DRUG-INDUCED BLOOD DYSCRASIAS IN SWEDEN [J].
BOTTIGER, LE ;
WESTERHOLM, B .
BMJ-BRITISH MEDICAL JOURNAL, 1973, 3 (5875) :339-343
[4]   APLASTIC ANAEMIA DUE TO PHENYLBUTAZONE [J].
CAMERON, EA ;
EISEN, AA ;
NIRANJAN, LM .
POSTGRADUATE MEDICAL JOURNAL, 1966, 42 (483) :49-+
[5]  
CHAPLIN S, 1986, ADV DRUG REACT ACUTE, V12, P97
[6]  
Dunn P S, 1972, Equine Vet J, V4, P63, DOI 10.1111/j.2042-3306.1972.tb03880.x
[7]   FATALITY DUE TO AGRANULOCYTOSIS FOLLOWING USE OF PHENYLBUTAZONE (BUTAZOLIDIN) [J].
ETESS, AD ;
JACOBSON, AS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1953, 151 (08) :639-640
[8]   Medical treatment of osteoarthritis in the horse - A review [J].
Goodrich, LR ;
Nixon, AJ .
VETERINARY JOURNAL, 2006, 171 (01) :51-69
[9]  
HALE G. S., 1960, MED JOUR AUSTRALIA II, V47, P449
[10]  
Hopes R, 1972, Equine Vet J, V4, P66, DOI 10.1111/j.2042-3306.1972.tb03881.x